Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas

Clinical trial NCT00844649 · COMPLETED

Trial details

NCT number: NCT00844649
Sponsor: Celgene
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Metastatic Pancreatic Cancer

Start date: 2009-03-01
Primary completion: 2012-09-17
Enrollment: 861

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.